Skip over navigation
Banner
Directory
Directory Search
Jobs
Job Search Post a Job
Patient
Patient Resources Drug Development
History
Genealogy
Toons & Teasers
Industry
 Directory
 Toons & Teasers
Quick Links
 Directory
 Job Search
 Toons & Teasers
 Advertising
 
Advertising
 

EquipNet Auction: Kaleido Biosciences - Complete Facility Closure - R&D Labs - Aug. 23

Check Out Our Newest Cartoon: "Milestones in Diabetes"

North American Biotech Roadshow Featuring Grad Students, Post-Docs & Start-Up “Do’s & Don’ts”


Publicly Traded Biotechnology & Medical Device
Companies with Headquarters in Washington State

The following includes publicly traded biotechnology and medical device companies headquartered in Washington State. Hyper links to company web sites and stock exchange are provided allowing you to obtain additional information about a specific company.

Company/Location Sector IPO Exchg. Symbol
Aptevo Therapeutics
Seattle, WA
Biotechnology 2016 NASDAQ APVO
Atossa Genetics Inc.
Seattle, WA
Biotechnology 2009 NASDAQ ATOS
BioLife Solutions, Inc.
Bothell, WA
Biotechnology 1998 OTCBB BLFS
Cell Therapeutics
Seattle, WA
Biotechnology 1997 NASDAQ CTIC
Cocrystal Pharma, Inc.
Bothell, WA
Pharmaceutical 2007 OTC BB COCP
CytoDyn Inc.
Vancouver, WA
Biotechnology 1994 OTCQB CYDY
Emergent BioSolutions Inc. (formerly Trubion) (1)
Seattle, WA
Biotechnology 2006 NYSE EBS
HaloSource, Inc.
Bothell, WA
Biotechnology 1998 LSE HALO.LN
Helix BioMedix, Inc.
Bothell, WA
Biotechnology 2000 OTCQB HXBM
IsoRay, Inc.
Richland, WA
Device 2005 AMEX ISR
Juno Therapeutics
Seattle, WA
Biotechnology 2005 NASDAQ JUNO
Marina Biotech, Inc.
Bothell, WA
Pharmaceutical 1983 OTCQX MRNA
NanoString Technologies, Inc.
Seattle, WA
Biotechnology 2003 NASDAQ NSTG
Omeros Corporation
Bothell, WA
Pharmaceutical 2009 NASDAQ OMER
OncoGenex Pharmaceuticals
Bothell, WA
Pharma 1991 NASDAQ OGXI
PhaseRx
Seattle, WA
Biotechnology 2006 NASDAQ PZRX
Seattle Genetics, Inc.
Bothell, WA
Biotechnology 2004 NASDAQ SGEN
ZymoGenetics, Inc. (2)
Seattle, WA
Biotechnology 2002 NYSE BMY

_____________________

(1) Emergent BioSolutions completed acquisition of Trubion Pharmaceuticals October 28, 2010.

(2) Bristol-Myers Squibb completed acquisition of ZymoGenetics, Inc. October 12, 2010.


Information is believed accurate but is not guaranteed.

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 1997 - 2022 Info.Resource, Inc. All rights reserved.
Privacy Policy . Cookie Policy . Terms of Use . About . Advertising

WashingtonLifeScience.com is owned and published by Info.Resource, Inc.